Beese Fulmer Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$349K Buy
696
+143
+26% +$68.6K 0.02% 265
2026
Q1
$272K Sell
553
-507
-48% -$275K 0.02% 332
2025
Q4
$615K Buy
1,060
+111
+12% +$62.8K 0.04% 183
2025
Q3
$460K Buy
949
+10
+1% +$4.66K 0.03% 197
2025
Q2
$381K Buy
939
+467
+99% +$195K 0.03% 209
2025
Q1
$235K Buy
472
+6
+1% +$3.25K 0.02% 219
2024
Q4
$242K Hold
466
0.02% 203
2024
Q3
$288K Buy
466
+1
+0.2% +$592 0.02% 193
2024
Q2
$257K Hold
465
0.02% 198
2024
Q1
$270K Hold
465
0.03% 193
2023
Q4
$247K Hold
465
0.03% 198
2023
Q3
$235K Hold
465
0.03% 191
2023
Q2
$243K Hold
465
0.03% 192
2023
Q1
$268K Sell
465
-21
-4% -$11.8K 0.03% 189
2022
Q4
$268K Buy
486
+21
+5% +$11.1K 0.03% 186
2022
Q3
$236K Hold
465
0.03% 185
2022
Q2
$253K Hold
465
0.03% 192
2022
Q1
$275K Sell
465
-250
-35% -$144K 0.03% 191
2021
Q4
$477K Hold
715
0.05% 161
2021
Q3
$409K Buy
715
+120
+20% +$65.9K 0.05% 166
2021
Q2
$300K Buy
595
+10
+2% +$4.72K 0.03% 180
2021
Q1
$267K Buy
+585
New +$279K 0.03% 184
2020
Q3
Sell
-335
Closed -$121K 507
2020
Q2
$121K Buy
+335
New +$112K 0.02% 227

Other funds holding TMO

Beese Fulmer Investment Management's TMO Position: Q2 2026 in Review

Beese Fulmer Investment Management increased its Thermo Fisher Scientific (TMO) stake by 26% in Q2 2026, buying an estimated $68.6K and bringing the position to 696 shares worth $349K. The position accounts for 0.02% of the portfolio, ranked #265.

Beese Fulmer Investment Management first reported a position in TMO in Q2 2020 and has held it in 23 quarters since. The position peaked at $615K in Q4 2025. 1,030 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Beese Fulmer Investment Management held 696 shares of Thermo Fisher Scientific worth $349K as of Q2 2026.
  • Beese Fulmer Investment Management bought 143 Thermo Fisher Scientific shares in Q2 2026, an estimated $68.6K.
  • Thermo Fisher Scientific made up 0.02% of Beese Fulmer Investment Management's portfolio in Q2 2026, its #265 holding.
  • Beese Fulmer Investment Management first reported a position in Thermo Fisher Scientific in Q2 2020 and has held it in 23 quarters since.
  • Beese Fulmer Investment Management's Thermo Fisher Scientific position peaked at $615K in Q4 2025.
  • 1,030 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Beese Fulmer Investment Management's 13F filing for Q2 2026, filed 29 Jul 2026.